These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 11393581)
1. Cyproterone acetate: a genotoxic carcinogen? Kasper P Pharmacol Toxicol; 2001 May; 88(5):223-31. PubMed ID: 11393581 [TBL] [Abstract][Full Text] [Related]
2. No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part I. Single dose treatment. Topinka J; Oesterle D; Reimann R; Wolff T Mutat Res; 2004 Jun; 550(1-2):89-99. PubMed ID: 15135643 [TBL] [Abstract][Full Text] [Related]
3. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity. Müller L; Gocke E; Lavé T; Pfister T Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141 [TBL] [Abstract][Full Text] [Related]
4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
5. Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation. Werner S; Kunz S; Wolff T; Schwarz LR Cancer Res; 1996 Oct; 56(19):4391-7. PubMed ID: 8813132 [TBL] [Abstract][Full Text] [Related]
6. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes. Werner S; Kunz S; Beckurts T; Heidecke CD; Wolff T; Schwarz LR Mutat Res; 1997 Dec; 395(2-3):179-87. PubMed ID: 9465929 [TBL] [Abstract][Full Text] [Related]
7. No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part II. Multiple dose treatment. Topinka J; Oesterle D; Reimann R; Wolff T Mutat Res; 2004 Jun; 550(1-2):101-8. PubMed ID: 15135644 [TBL] [Abstract][Full Text] [Related]
8. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Bolt HM; Foth H; Hengstler JG; Degen GH Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638 [TBL] [Abstract][Full Text] [Related]
9. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Gaylor DW Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536 [TBL] [Abstract][Full Text] [Related]
10. Antigenotoxic role of Centella asiatica L. extract against cyproterone acetate induced genotoxic damage in cultured human lymphocytes. Siddique YH; Ara G; Beg T; Faisal M; Ahmad M; Afzal M Toxicol In Vitro; 2008 Feb; 22(1):10-7. PubMed ID: 17719740 [TBL] [Abstract][Full Text] [Related]
11. DNA fragmentation, DNA repair and apoptosis induced in primary rat hepatocytes by dienogest, dydrogesterone and 1,4,6-androstatriene-17beta-ol-3-one acetate. Mattioli F; Garbero C; Gosmar M; Manfredi V; Carrozzino R; Martelli A; Brambilla G Mutat Res; 2004 Nov; 564(1):21-9. PubMed ID: 15474407 [TBL] [Abstract][Full Text] [Related]
12. The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue transgenic F344 rats. Krebs O; Schäfer B; Wolff T; Oesterle D; Deml E; Sund M; Favor J Carcinogenesis; 1998 Feb; 19(2):241-5. PubMed ID: 9498271 [TBL] [Abstract][Full Text] [Related]
13. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds. Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
15. Genotoxicity of environmental agents assessed by the alkaline comet assay. Møller P Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009 [TBL] [Abstract][Full Text] [Related]
16. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514 [TBL] [Abstract][Full Text] [Related]
17. Genotoxic potential of cyproterone acetate: a possible role of reactive oxygen species. Siddique YH; Afzal M Toxicol In Vitro; 2005 Feb; 19(1):63-8. PubMed ID: 15582357 [TBL] [Abstract][Full Text] [Related]
18. Differences in DNA damage and repair produced by systemic, hepatocarcinogenic and sarcomagenic dibenzocarbazole derivatives in a model of rat liver progenitor cells. Valovicová Z; Marvanová S; Mészárosová M; Srancíková A; Trilecová L; Milcová A; Líbalová H; Vondrácek J; Machala M; Topinka J; Gábelová A Mutat Res; 2009 Jun; 665(1-2):51-60. PubMed ID: 19427511 [TBL] [Abstract][Full Text] [Related]
19. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261 [TBL] [Abstract][Full Text] [Related]
20. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment. Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]